Frontiers in Pharmaceutical Sciences Lecture Series - No. 175
New Specific Copper Chelators as Potential Therapeutic Agents for Alzheimer's Disease
Topic: New Specific Copper Chelators as Potential Therapeutic Agents for Alzheimer's Disease
Speaker:Prof. Bernard Meunier, Laboratoire de Chimie de Coordination du CNRS
Chair: Prof. Zhishu Huang, School of Pharmaceutical Science, Sun Yat-sen University
Time: Monday, March 31th, 2014, 10:00 AM
Venue: 125 Meeting Room, School of Pharmaceutical Sciences, East Campus, SYSU
Introduction of the speaker:
Prof. Bernard Meunier, the Academician of French Academy of Sciences, Foreign Academician of Polish Academy of Sciences. He served as the president of Centre National de la Recherche Scientifique (CNRS) and Chief Executive Officer of PALUMED SA Corporation. Prof. Meunier is expert in the field of medicinal chemistry and organic chemistry, and he contributed himself to the research of chemistry and made significant achievements. He obtained Knight of the French Legion of Honor in 2006 and Descartes - Huygens Awards of Royal Netherlands Academy in 2001. Two new drugs developed by Prof. Meunier and his team have been approved into the market. Prof. Bernard Meunier was appointed as the Leading Talents of Guangdong Province and serves at the Guangdong University of Technology. His research project in the laboratory in China is “the Development of new metal chelator based Anti-dementia drugs”.
Prof. Meunier has obtained 32 patents and published 378 research papers. His articles are cited more than 14,426 times and his single article is cited more than 1500 times. He used to serve as the chief editor of Eur. J. Inorg. Chem., and member of editorial board of Angewandte Chemie Int. Ed., Acc. Chem. Res., ChemBioChem., J. Bioinorg. Chem., J. Mol. Catal., J. Organomet. Chem., J. Org. Phys. Chem.
All are welcome to the lecture!